Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, E.S. | - |
dc.contributor.author | Kim, M.K. | - |
dc.contributor.author | Kang, H.K. | - |
dc.contributor.author | Park, Y.I. | - |
dc.contributor.author | Dong, M.S. | - |
dc.contributor.author | Kim, D.H. | - |
dc.contributor.author | Chung, H.S. | - |
dc.date.accessioned | 2024-01-20T22:30:19Z | - |
dc.date.available | 2024-01-20T22:30:19Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2008-12 | - |
dc.identifier.issn | 1226-3907 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/132963 | - |
dc.description.abstract | The aerial parts of Epimedium koreanum Nakai have been used to stimulate hormone secretion in treating impotence. Ten flavonol glycosides, 3,4,5-trihydroxy-8-prenylflavone 7-O-[β-D-glucopyranosyl(1 → 2)-β-D-glucopyranoside] (1), hyperoside (2), icarisid II (3), 2″-O-Rhamnosylicarisid II (4), epimedin A (5), epimedin B (6), epimedin C (7), icariin (8), hexandraside E (9), and epimedoside A (10) were isolated from the an ethylacetate soluble extracts of the aerial parts of Epimedium koreanum Nakai through activity-monitord fractionation and isolation method. The structures of compounds 1 - 10 were elucidated by high resolution fast atom bombardment mass spectrometry and two dimentional nuclear magnetic resonance spectroscopy analysis. Compounds 1 and 4 showed potent antioxidant activity, with IC50 values of 19.7 and 11.5 μg/mL and 88.2 and 90.5 μM, respectively. | - |
dc.language | English | - |
dc.subject | 2&apos | - |
dc.subject | o rhamnosylicarisid II | - |
dc.subject | 3,4,5 trihydroxy 8 prenylflavone 7 o [beta dextro glucopyranosyl (1-2) beta dextro glucopyranoside] | - |
dc.subject | acetic acid ethyl ester | - |
dc.subject | ascorbic acid | - |
dc.subject | butylated hydroxyanisole | - |
dc.subject | epimedin A | - |
dc.subject | epimedin B | - |
dc.subject | epimedin C | - |
dc.subject | epimedoside A | - |
dc.subject | flavonoid glycoside | - |
dc.subject | free radical | - |
dc.subject | hexandraside E | - |
dc.subject | hyperin | - |
dc.subject | icariin | - |
dc.subject | icarisid II | - |
dc.subject | plant glycoside | - |
dc.subject | unclassified drug | - |
dc.subject | antioxidant activity | - |
dc.subject | article | - |
dc.subject | drug isolation | - |
dc.subject | drug potency | - |
dc.subject | drug structure | - |
dc.subject | Epimedium | - |
dc.subject | Epimedium koreanum | - |
dc.subject | fast atom bombardment mass spectrometry | - |
dc.subject | fractionation | - |
dc.subject | hormone release | - |
dc.subject | IC 50 | - |
dc.subject | impotence | - |
dc.subject | nuclear magnetic resonance spectroscopy | - |
dc.title | Flavonol glycosides with antioxidant activity from the aerial parts a of Epimedium koreanum Nakai | - |
dc.type | Article | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Natural Product Sciences, v.14, no.4, pp.233 - 238 | - |
dc.citation.title | Natural Product Sciences | - |
dc.citation.volume | 14 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 233 | - |
dc.citation.endPage | 238 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.scopusid | 2-s2.0-58249096133 | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | 2&apos | - |
dc.subject.keywordPlus | o rhamnosylicarisid II | - |
dc.subject.keywordPlus | 3,4,5 trihydroxy 8 prenylflavone 7 o [beta dextro glucopyranosyl (1-2) beta dextro glucopyranoside] | - |
dc.subject.keywordPlus | acetic acid ethyl ester | - |
dc.subject.keywordPlus | ascorbic acid | - |
dc.subject.keywordPlus | butylated hydroxyanisole | - |
dc.subject.keywordPlus | epimedin A | - |
dc.subject.keywordPlus | epimedin B | - |
dc.subject.keywordPlus | epimedin C | - |
dc.subject.keywordPlus | epimedoside A | - |
dc.subject.keywordPlus | flavonoid glycoside | - |
dc.subject.keywordPlus | free radical | - |
dc.subject.keywordPlus | hexandraside E | - |
dc.subject.keywordPlus | hyperin | - |
dc.subject.keywordPlus | icariin | - |
dc.subject.keywordPlus | icarisid II | - |
dc.subject.keywordPlus | plant glycoside | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | antioxidant activity | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | drug isolation | - |
dc.subject.keywordPlus | drug potency | - |
dc.subject.keywordPlus | drug structure | - |
dc.subject.keywordPlus | Epimedium | - |
dc.subject.keywordPlus | Epimedium koreanum | - |
dc.subject.keywordPlus | fast atom bombardment mass spectrometry | - |
dc.subject.keywordPlus | fractionation | - |
dc.subject.keywordPlus | hormone release | - |
dc.subject.keywordPlus | IC 50 | - |
dc.subject.keywordPlus | impotence | - |
dc.subject.keywordPlus | nuclear magnetic resonance spectroscopy | - |
dc.subject.keywordAuthor | 2D-NMR | - |
dc.subject.keywordAuthor | Antioxidant | - |
dc.subject.keywordAuthor | Berberidaceae | - |
dc.subject.keywordAuthor | Epimedium koreanum | - |
dc.subject.keywordAuthor | HR-FABMS | - |
dc.subject.keywordAuthor | Prenylated flavonol glycoside | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.